Contrast Media Injectors

April 18, 2014 — Guerbet announced that Lipiodol was approved by the U.S. Food and Drug Administration (FDA), indicated for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving iopa...

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in...

For the first time, researchers have confirmed an association between a common magnetic resonance imaging (MRI) contrast agent and abnormalities on brain MRI, according to a new study published online in the journal Radiology. The ne...

April 18, 2014 — Guerbet announced that Lipiodol was approved by the U.S. Food and Drug Administration (FDA), indicated for selective hepatic intra-arterial...
Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud
GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort,...
Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.
Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray
Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in X-ray medical examinations. FlowSens received...
Guerbet's Lipiodol is indicated for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (
Bracco Diagnostics Inc. syringe packs with spikes are to be used when loading contrast and saline for delivery with power injectors in...
The PosiRx 3000-Series is Positron Corp.'s latest pharmacy automation systems. The PosiRx 3000-Series are the first systems to...
Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast...

Articles

April 18, 2014 — Guerbet announced that Lipiodol was approved by the U.S. Food and Drug Administration (FDA), indicated for selective hepatic intra-arterial...
Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud
GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort,...
Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray
Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in X-ray medical examinations. FlowSens received...
March 5, 2014 — Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery have developed a...

Video Center

The 24th Annual Interdisciplinary Breast Center Conference (NCoBC 2014), sponsored by the National...
3 weeks 5 days ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
5 weeks 9 hours ago
Vienna is to the European Congress of Radiology what Chicago is to RSNA. This year the ECR...
5 weeks 4 days ago
This webinar will allow clinicians to learn more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available applications and technologies include...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
Lydia Liao spectral mammography
During this webinar, Lydia Liao,  M.D., Ph.D., M.P.H., presented an overview of contrast-enhanced spectral mammography technology and shared cases where SenoBright has...

Comparison Charts